Tentative TRIPS Waiver Granted COVID-19

Tentative TRIPS Waiver Granted COVID-19

Published On: 03/17/2022Tags: Agencies, Biopharma

Mach In Slow Trot: Xtandi’s Reinvigorates Government IP Rights Debate

Access memo here

What insights can we share with you?

Contact Info

900 19th Street Northwest
Washington, DC 20006
United States

[email protected]

PastedGraphic-26